Inari is an agtech startup that combines cutting-edge technology with a deep understanding of plant genetics to develop crops that are not only high-yielding but also adapted to local environments. Inari’s innovative approach is centered around the use of CRISPR gene-editing technology to precisely tailor plant traits. This technology allows scientists at Inari to accelerate the breeding process, creating crops with desirable characteristics such as increased yield, resistance to pests and diseases, and adaptability to diverse environmental conditions.
Inari has raised $103 million of new equity at a $1.65 billion valuation. Existing investors Hanwha Impact, Canadian pension giant CPP Investments, Rivas Capital, NGS Super, State of Michigan Retirement System, and Flagship Pioneering participated in the round. Moreover, new investors such as the RCM Private Markets fund, an affiliate of Rokos Capital Management also participated in the new round.
Inari, Cambridge, Massachusetts, United States, was founded in 2016 by David Berry, Ignacio Martinez, and John Casey. “This fundraise comes at an exciting time for the company, helping to further advance our cutting-edge technologies and enter the commercialization phase – bringing our breakthrough products into the hands of seed customers,” said Inari Chief Executive Officer Ponsi Trivisvavet.
